TY - JOUR KW - Adenosine Triphosphate KW - Animals KW - Chromatography, High Pressure Liquid KW - Dapsone KW - Drug Interactions KW - Leprostatic Agents KW - leprosy KW - Mice KW - Mice, Inbred BALB C KW - Microbial Sensitivity Tests KW - Mycobacterium leprae KW - Receptors, Fc KW - Thymidine KW - Trimethoprim AU - Seydel J K AU - Wempe E G AU - Rosenfeld M AU - Jagannathan R AU - Mahadevan P R AU - Dhople A M AB -

The antibacterial effect of brodimoprim alone and in combination with dapsone has been studied in vitro in cell-free systems and in whole mycobacterial cells as well as in vivo in mice and humans. The obtained inhibitory effects in vitro and in vivo against model mycobacterial strains and M. leprae, the pharmacokinetic properties in human and its synergistic effect with the most used drug in the chemotherapy of leprosy, dapsone, make brodimoprim a promising candidate in the therapy of leprosy.

BT - Arzneimittel-Forschung C1 - http://www.ncbi.nlm.nih.gov/pubmed/2187440?dopt=Abstract DA - 1990 Jan IS - 1 J2 - Arzneimittelforschung LA - eng N2 -

The antibacterial effect of brodimoprim alone and in combination with dapsone has been studied in vitro in cell-free systems and in whole mycobacterial cells as well as in vivo in mice and humans. The obtained inhibitory effects in vitro and in vivo against model mycobacterial strains and M. leprae, the pharmacokinetic properties in human and its synergistic effect with the most used drug in the chemotherapy of leprosy, dapsone, make brodimoprim a promising candidate in the therapy of leprosy.

PY - 1990 SP - 69 EP - 75 T2 - Arzneimittel-Forschung TI - In vitro and in vivo experiments with the new inhibitor of mycobacterium leprae brodimoprim alone and in combination with dapsone. VL - 40 SN - 0004-4172 ER -